Filter
6001
Filtered Results: 6001
Text search:
Assessment,
monitoring
and
evaluation
Featured
Recommendations
596
New Publications
1754
Language
Document type
No document type
3618
Studies & Reports
797
Guidelines
797
Manuals
350
Strategic & Response Plan
250
Training Material
83
Fact sheets
52
Situation Updates
34
Resource Platforms
8
Infographics
6
Brochures
5
Online Courses
1
Countries / Regions
India
245
Global
242
Kenya
204
Ethiopia
147
Uganda
133
Sierra Leone
124
Nepal
123
South Africa
122
Nigeria
121
Liberia
109
Western and Central Europe
109
Myanmar / Burma
103
Malawi
98
Tanzania
97
Ghana
92
Zambia
92
Rwanda
92
Africa
75
Bangladesh
74
Syria
67
Ukraine
67
Latin America and the Carribbean
61
Philippines
57
Namibia
53
Congo, Democratic Republic of
48
Lesotho
41
Eastern Europe
41
Cambodia
40
South–East Asia Region
39
Zimbabwe
34
Guinea
33
South Sudan
33
West and Central Africa
33
Indonesia
32
East and Southern Africa
30
Mozambique
29
Haiti
28
Senegal
27
Middle East and North Africa
26
Botswana
25
Russia
23
Germany
22
Asia
22
Eastern Europe and Central Asia
21
Cameroon
20
Jordan
20
Brazil
20
Burkina Faso
19
Pakistan
19
Yemen
19
Afghanistan
18
Benin
18
Lebanon
16
Eswatini/ Swaziland
16
Sudan
13
Western Pacific Region
13
USA
12
Somalia
12
Iraq
12
Vietnam
12
Mali
10
Thailand
10
Venezuela
10
Laos
10
Tajikistan
10
Colombia
9
Albania
9
Turkey
8
China
7
Madagascar
7
Georgia
7
Angola
6
Sri Lanka
6
Iran
6
Saudi Arabia
5
Egypt
5
Central African Republic
5
Argentina
5
Peru
5
Libya
5
Timor Leste/ East Timor
5
Côte d’Ivoire / Ivory Coast
4
Niger
4
Chad
4
Gambia
4
Paraguay
4
Bhutan
4
Southern Africa
4
Moldova
4
Kyrgyzstan
4
Spain
4
Mauritania
3
North Macedonia
3
Croatia
3
Burundi
3
Palestine
3
Armenia
3
Canada
3
Qatar
3
Kazakhstan
3
North America
3
United Kingdom
3
Portugal
3
Bosnia and Herzegovina
3
Guinea-Bissau
2
Morocco
2
Togo
2
Singapore
2
Serbia
2
Honduras
2
Bolivia
2
Greece
2
Mexico
2
Italy
2
Estonia
2
Romania
2
Lithuania
2
Turkmenistan
2
France
2
Mauritius
2
Tunisia
2
Israel
2
Malaysia
1
Ireland
1
Papua New Guinea
1
Vanuatu
1
Dominican Republic
1
Ecuador
1
El Salvador
1
Guatemala
1
Nicaragua
1
Chile
1
Fiji
1
Poland
1
North Korea
1
Djibouti
1
Congo-Brazzaville
1
Bulgaria
1
Uruguay
1
Jamaica
1
Japan
1
Denmark
1
Maldives
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
2295
Clinical Guidelines
487
Key Resources
368
Public Health
351
Women & Child Health
324
Capacity Building
125
Pharmacy & Technologies
64
Toolboxes
HIV
429
Mental Health
391
COVID-19
354
TB
322
Disability
225
Planetary Health
202
Rapid Response
200
AMR
185
Conflict
171
Ebola
170
Caregiver
169
NTDs
128
NCDs
109
Natural Hazards
100
Pharmacy
98
Global Health Education
87
Refugee
85
Specific Hazards
43
Health Financing Toolbox
38
Cholera
33
Polio
32
Zika
32
Social Ethics
7
Typhoon
5
South Sudan
1
Health Financing
1
Based on WHO South-East Asia Regional Strategy on Autism Spectrum Disorder
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder ... the issues faced by PwASD and their caregivers; the foundation on which the Regional Strategy and the collaborative framework is based; desired outcomes against each objective of the ASD Regional Strategy; recommended actions to fulfill each objective; requisite parameters that should govern the recommended actions; and suggested guidelines for monitoring, evaluating and reporting a Member State’s progress towards fulfilling the objectives. It encourages Member States to share best practices and information for promoting cooperation and partnerships for development of effective and sustainable programmes.
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder ... the issues faced by PwASD and their caregivers; the foundation on which the Regional Strategy and the collaborative framework is based; desired outcomes against each objective of the ASD Regional Strategy; recommended actions to fulfill each objective; requisite parameters that should govern the recommended actions; and suggested guidelines for monitoring, evaluating and reporting a Member State’s progress towards fulfilling the objectives. It encourages Member States to share best practices and information for promoting cooperation and partnerships for development of effective and sustainable programmes.
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
The ongoing COVID-19 pandemic has shown that public financial management (PFM) should be an integral part of the response. Effectiveness in financing the health response depends not only on the level of funding but also on the way public funds are allocated ... spent, this is determined by the PFM rules, and how money flows to health service providers. So far, early assessments have shown that PFM systems ranged from being a fundamental enabler to acting as a roadblock in the COVID-19 health response. While service delivery mechanisms have been extensively documented throughout the pandemic, the underlying PFM mechanisms of the response also merit attention. To highlight the importance of PFM in health emergency contexts, this rapid review analyses various country PFM experiences and identifies early lessons emerging from the financing of the health response to COVID-19. The assessment is done by stages of the budget cycle: budget allocation, budget execution, and budget oversight. Identifying lessons from the varying PFM modalities used to finance the response to COVID-19 is fundamental both for health policy-makers and for finance authorities to prepare for future health emergencies.
Confronted with the important issue of patient safety, in 2002 the Fifty-fifth World Health Assembly adopted a resolution urging countries to pay the closest possible attention to the problem and to strengthen safety ... monitoring systems. In May 2004, the Fifty-seventh World Health Assembly approved the creation of an international alliance as a global initiative to improve patient safety. The World Alliance for Patient Safety was launched in October 2004 and currently has its place in the WHO Patient Safety programme included in the Information, Evidence and Research Cluster.
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigma...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
TNew data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths.
According to WHO’s latest World malaria report, there were an estimated 241 million m...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity ... mortality in children living in areas of moderate to high malaria transmission. It also incorporates findings from the evaluation of the WHO-coordinated Malaria Vaccine Implementation Programme (MVIP), recommended by SAGE and MPAG in 2015, and from additional studies since 2015.
This paper does not include findings on vaccine efficacy in infants first vaccinated at 6–12 weeks of age. Because of the lower vaccine efficacy observed in this age category, WHO did not recommend pilot implementation or RTS,S/AS01 vaccine introduction for these young infants. Recommendations2 on the use of RTS,S/AS01 vaccine were discussed by SAGE and MPAG during a joint session in October 2021; evidence presented at the meeting can be accessed at https://terrance.who.int/mediacentre/data/ sage/SAGE_eYB_Oct2021.pdf
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured patient training, and ... of blood glucose levels. The guidelines emphasize preventing complications like ketoacidosis and hypoglycemia while improving patients' quality of life through education and tailored medical care. Recommendations include the use of both basal and bolus insulin, continuous glucose monitoring, and integrating psychosocial support into treatment plans. The document serves as a comprehensive resource for healthcare professionals managing Type 1 Diabetes.
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, ... biomedical engineering resources. This publication is intended for use as a reference by decision-makers in Ministries of Health, nongovernmental organizations and academic institutions involved in health technology at the district, national, regional, or global levels.
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immuniz...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that ... of five leading vaccine manufacturers, AstraZeneca plc, BioNTech SE, Johnson & Johnson, Moderna Inc., and Pfizer Inc. It also includes for the first time an assessment of the two largest Chinese vaccine producers, China National Pharmaceutical Group Co., Ltd. (Sinopharm) and Sinovac Biotech Ltd. (Sinovac).
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of fil...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatmen...
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, ... the opportunities provided by new technology. Assessments carried out under the IHR show
continuing gaps in capacity for managing chemicals (2). In particular, many countries still lack access to poison
centre services (3). There is therefore demand for updated guidance.
Global Biodiversity Outlook (GBO) is the flagship publication of the Convention on Biological Diversity (CBD). It is a periodic report that summarizes the latest data on the status and trends of biodiversity ... draws conclusions relevant to the further implementation of the Convention.
GBO-5 provides global summary of progress towards the Aichi Biodiversity Targets and is based on a range of indicators, research studies and assessments (in particular the IPBES Global Assessment on Biodiversity and Ecosystem Services), as well as the national reports provided by countries on their implementation of the CBD. The national reports provide rich information about the steps taken in countries worldwide in support of biodiversity conservation, sustainable use, and the fair and equitable sharing of benefits. This body of Information provides a wealth of information on the successes and challenges in implementing the Strategic Plan for Biodiversity 2011-2020 and in reaching the Aichi Biodiversity Targets.
This Outlook draws on the lessons learned during the first two decades of this century to clarify the transitions needed if we are to realize the vision agreed by world governments for 2050, ‘Living in Harmony with Nature’. You can download the report in several languages
1 June 2020
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Mainta...
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essenti...
This manual will aid in building the capacity of nurses with clinical knowledge of the unique needs, complex health problems, common geriatric syndromes, and principles of care of older people. It will also enable them to acquire the skills necessar...
